Novartis / To / AT&T / Insource Services Inc. / Cytokinetics / Boston Business Journal / TDI / Third Rock Ventures / UCB Pharma / /
Country
United States / /
Currency
USD / / /
Event
FDA Phase / /
Facility
Technology Square / Fairmont Copley Hotel / Mass General Hospital / Westin Copley Place Hotel / Methodist Neurological Institute / University of California / ALS Therapy Development Institute / /
IndustryTerm
machinery / incredible new tool / pharmaceutical / healthcare / potential tool / treatment of MS / iPS technology / /
MedicalCondition
ALS / MS / disease / both understanding disease / /
MedicalTreatment
stem cell therapies / /
Organization
Mass General Hospital in Boston / University of California / Stanford School of Medicine / Methodist Neurological Institute in Houston / ALS / International Society of Stem Cell Research / ALS Therapy Development Institute / FDA / Cystic Fibrosis Foundation / /
Person
Willem van Weperen Amelie Gubitz / Shinya Yamanaka / Philip Reilly / Karen Sepucha / Steve Finkbeiner / Julie Donnelly / Amelie Gubitz / Mike Gold / Fernando Vieira / Willem van Weperen / John Lincecum / Aaron Gitler / Robert Beall / Steve Perrin / Gladstone Institutes / Joseph Gann Jewelers / Academic / Jenna Sills / / /
Position
investigator / director / extramural research program / program director / principal investigator / VP clinical therapeutic area CNS / CEO and chief scientific officer / premier / model of medical research / CEO / leader / President and CEO / associate director and senior investigator / healthcare and life sciences reporter / professor of Genetics / President & CEO / associate professor / /
Fall[removed]NEWSLETTER Message from our President and CEO